Australia's EMVision soars on successful study result of diagnostic tech

EMvision Medical Devices

12/11/2024 01:05

** Shares of EMVision Medical Devices  EMV.AX  rise as much
as 17.7% to A$2.1, their best trading session since early March
    ** Shares hit their highest level since Oct. 22
    ** Medical equipment and tech co reports successful results
from its neurodiagnostic technology for early identification of
stroke and stroke types
    ** Says study highlights sensing capabilities, including
successful detection and classification of very small
haemorrhages
    ** Adds AI-based diagnostic models demonstrated improved
performance as additional clinical data was provided
    ** More than 78,000 shares change hands vs 30-day avg volume
of around 35,000 shares
    ** YTD, EMV up 21.5% as of 0100 GMT

 (Reporting by Nikita Maria Jino in Bengaluru)
 ((Nikita.Jino@thomsonreuters.com))